Clinical Trials in Boston

Showing 12121-12140 of 17,836 trials

Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma

NCT00231166

The purpose of this study is to determine the highest tolerated dose, safety and activity of HCD122 in patients with Multiple Myeloma who are relapsed after receiving prior treatment.

Multiple Myeloma

Novartis Pharmaceuticals33 participantsStarted Sep 2005

Boston, Massachusetts, United States • New York, New York, United States • Portland, Oregon, United States +4 more locations

COMPLETEDNA< 1 mile

Telecommunications System in Sleep Apnea

NCT00232544

This study is investigating the effects of a telecommunications system designed to improve patient adherence with prescribed positive airway pressure (CPAP).

Sleep Apnea, Obstructive

VA Office of Research and Development250 participantsStarted Oct 2004

Boston, Massachusetts, United States

TERMINATEDPhase 1< 1 mile

A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders

NCT02354443

The purpose of this study is to describe the safety profile of ProHema-CB as part of a single cord blood unit transplant after a myeloablative conditioning regimen in pediatric patients with inherited metabolic disorders. The safety profile will primarily be assessed by neutrophil engraftment.

Metabolic Disorders

Fate Therapeutics1 participantsStarted Jun 2015

Boston, Massachusetts, United States • Durham, North Carolina, United States

Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma

Telecommunications System in Sleep Apnea

A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders

Find Trials by Condition in Boston

A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies

A Study of Effects of Age and Hyperkyphosis on Spine Motion and Loading

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Portable Visual Guidance System Phase II

Multicenter Continuous Peripheral Nerve Block Surveillance Study

Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment

A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Intrapartum Vancomycin for Group B Streptococcus (GBS) Prophylaxis

Cancer of the Uterus and Treatment of Stress Urinary Incontinence

Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase

Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial

Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study

30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event

Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD Patients

Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer

Gastric Electrical Stimulation (GES) for the Treatment of Obesity